查看購物車
  • English
  • Japanese
  • Korean
2026-2030年全球分子影像（MI）技術市場
市場調查報告書
商品編碼
2126178

2026-2030年全球分子影像（MI）技術市場

Global Molecular Imaging (MI) Technologies Market 2026-2030
出版日期: | 出版商: TechNavio | 英文 320 Pages | 訂單完成後即時交付

價格
簡介目錄

全球分子影像（MI）技術市場預計將從 2025 年到 2030 年成長至 39.454 億美元，預測期內複合年成長率為 8.8%。

本報告對全球分子成像（MI）技術市場進行了全面分析，包括市場規模和預測、趨勢、成長要素、挑戰以及涵蓋約 25 家供應商的供應商分析。

本報告對當前市場狀況、最新趨勢和促進因素以及整體市場環境進行了最新分析。該市場的成長主要受慢性病盛行率上升、混合設備技術進步以及精準醫療領域不斷拓展的推動。

本研究客觀地結合了一手和二手訊息，包括主要行業相關人員的意見。報告內容涵蓋主要公司分析、全面的市場規模數據、區域細分分析以及供應商格局。報告包含歷史數據和預測數據。

市場範圍
基準年 2025
年末 2030
調查期 2026-2030
成長勢頭 加速度
與 2026 年相比 8.1%
複合年成長率 8.8%
增量 39.454億美元

本研究指出，診療一體化藥物的日益普及將是未來幾年全球分子影像（MI）技術市場成長的主要驅動力之一。此外，數位迴旋加速器基礎設施的建造和定量成像生物標記的出現預計也將帶來顯著的市場需求。

目錄

第1章：執行摘要

第2章 Technavio 分析

  • 分析定價、生命週期、顧客購買籃子、採用率和購買標準。
  • 輸入的重要性及差異化因素
  • 干擾因素
  • 促進因素和挑戰的影響

第3章 市場狀況

  • 市場生態系統
  • 市場特徵
  • 價值鏈分析

第4章 市場規模

  • 市場的定義
  • 市場區隔分析
  • 2025年市場規模
  • 市場展望，2025-2030年

第5章 市場規模與表現

  • 2020-2024年全球分子影像（MI）技術市場
  • 2020年至2024年最終用戶細分市場分析
  • 基於應用領域的細分市場分析，2020-2024 年
  • 基於模式的細分市場分析，2020-2024 年
  • 區域區隔市場分析，2020-2024 年
  • 2020-2024年各國細分市場分析

第6章 定性分析

  • 人工智慧的影響：全球分子影像（MI）技術市場
  • 地緣政治衝突對全球分子成像（MI）技術市場的影響。

第7章：五力分析

第8章 市場區隔：依最終用戶分類

  • 比較：按最終用戶
  • 醫院和診所
  • 研究機構
  • 製藥公司
  • 受託研究機構
  • 其他
  • 市場機會：依最終用戶分類

第9章 市場區隔：依應用

  • 比較：透過應用
  • 腫瘤學
  • 循環系統
  • 神經病學
  • 感染疾病
  • 其他
  • 市場機會：依應用領域分類

第10章 市場區隔：依治療方式

  • 比較：依模態
  • PET
  • SPECT
  • 混合影像診斷系統
  • 其他
  • 市場機會：依治療方式分類

第11章 客戶情況

第12章 區域情勢

  • 區域細分
  • 區域比較
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
  • 亞洲
    • 中國
    • 印度
    • 日本
    • 韓國
    • 印尼
    • 泰國
  • 世界其他地區（RoW）
    • 巴西
    • 沙烏地阿拉伯
    • UAE
    • 土耳其
    • 阿根廷
    • 哥倫比亞
    • 南非
    • 以色列
  • 市場機會：按地區分類

第13章 促進因素、挑戰與機遇

  • 市場促進因素
  • 市場挑戰
  • 促進因素和挑戰的影響
  • 市場機遇

第14章 競爭格局

  • 概述
  • 競爭格局
  • 混亂局面
  • 產業風險

第15章 競爭分析

  • 公司簡介
  • 公司排名指標
  • 企業市場定位
  • Aspect Imaging Ltd.
  • Bruker Corp.
  • Canon Medical Systems Corp.
  • FUJIFILM Holdings Corp.
  • GE HealthCare Technologies
  • Koninklijke Philips NV
  • Lantheus
  • LI COR Inc.
  • MR Solutions Ltd.
  • Revvity Inc.
  • Rigaku Corp.
  • Shanghai United Imaging
  • Shimadzu Corp.
  • Siemens Healthineers AG
  • Spectrum Dynamics Medical Inc.

第16章附錄

簡介目錄
Product Code: IRTNTR80343

The global molecular imaging (MI) technologies market is forecasted to grow by USD 3945.4 mn during 2025-2030, accelerating at a CAGR of 8.8% during the forecast period. The report on the global molecular imaging (MI) technologies market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising prevalence of chronic disease, technological advancements in hybrid equipment, expansion of precision medicine initiatives.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Market Scope
Base Year2025
End Year2030
Series Year2026-2030
Growth MomentumAccelerate
YOY 20268.1%
CAGR8.8%
Incremental Value$3945.4 mn

Technavio's global molecular imaging (MI) technologies market is segmented as below:

By End-User

  • Hospitals and clinics
  • Research institutes
  • Pharmaceutical companies
  • Contract research organizations
  • Others

By Application

  • Oncology
  • Cardiology
  • Neurology
  • Infectious diseases
  • Others

By Modality

  • PET
  • SPECT
  • Hybrid imaging systems
  • Others

Geography

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • The Netherlands
  • Asia
  • Rest of World (ROW)
  • Rest of World (ROW)

This study identifies the expansion of theranostic agent applications as one of the prime reasons driving the global molecular imaging (mi) technologies market growth during the next few years. Also, growth of digital cyclotron infrastructure and rise of quantitative imaging biomarkers will lead to sizable demand in the market.

The report on the global molecular imaging (mi) technologies market covers the following areas:

  • Global molecular imaging (mi) technologies market sizing
  • Global molecular imaging (mi) technologies market forecast
  • Global molecular imaging (mi) technologies market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global molecular imaging (mi) technologies market vendors that include Aspect Imaging Ltd., Bruker Corp., Canon Medical Systems Corp., Cubresa Inc., Curium Pharma, FUJIFILM Holdings Corp., GE HealthCare Technologies, Koninklijke Philips NV, Lantheus, LI COR Inc., Lucerno Dynamics Inc., Mediso Ltd., MinFound Medical Systems Co. Ltd., MR Solutions Ltd., Positrigo AG, RefleXion Medical Inc., Revvity Inc., Rigaku Corp., Shanghai United Imaging, Shimadzu Corp., Siemens Healthineers AG, Spectrum Dynamics Medical Inc.. Also, the global molecular imaging (mi) technologies market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

  • 1.1 Market overview
    • Executive Summary - Chart on Market Overview
    • Executive Summary - Data Table on Market Overview
    • Executive Summary - Chart on Global Market Characteristics
    • Executive Summary - Chart on Market by Geography
    • Executive Summary - Chart on Market Segmentation by End-user
    • Executive Summary - Chart on Market Segmentation by Application
    • Executive Summary - Chart on Market Segmentation by Modality
    • Executive Summary - Chart on Incremental Growth
    • Executive Summary - Data Table on Incremental Growth
    • Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

  • 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
    • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • 2.2 Criticality of inputs and Factors of differentiation
  • 2.3 Factors of disruption
  • 2.4 Impact of drivers and challenges

3 Market Landscape

  • 3.1 Market ecosystem
  • 3.2 Market characteristics
  • 3.3 Value chain analysis

4 Market Sizing

  • 4.1 Market definition
  • 4.2 Market segment analysis
    • Market segments
  • 4.3 Market size 2025
  • 4.4 Market outlook: Forecast for 2025-2030

5 Historic Market Size

  • 5.1 Global Molecular Imaging (MI) Technologies Market 2020 - 2024
    • Historic Market Size - Data Table on Global Molecular Imaging (MI) Technologies Market 2020 - 2024 ($ million)
  • 5.2 End-user segment analysis 2020 - 2024
    • Historic Market Size - End-user Segment 2020 - 2024 ($ million)
  • 5.3 Application segment analysis 2020 - 2024
    • Historic Market Size - Application Segment 2020 - 2024 ($ million)
  • 5.4 Modality segment analysis 2020 - 2024
    • Historic Market Size - Modality Segment 2020 - 2024 ($ million)
  • 5.5 Geography segment analysis 2020 - 2024
    • Historic Market Size - Geography Segment 2020 - 2024 ($ million)
  • 5.6 Country segment analysis 2020 - 2024
    • Historic Market Size - Country Segment 2020 - 2024 ($ million)

6 Qualitative Analysis

  • 6.1 Impact of AI on Global Molecular Imaging (MI) Technologies Market
  • 6.2 Impact of geopolitical conflicts on Global Molecular Imaging (MI) Technologies Market

7 Five Forces Analysis

  • 7.1 Five forces summary
    • Five forces analysis - Comparison between 2025 and 2030
  • 7.2 Bargaining power of buyers
    • Bargaining power of buyers - Impact of key factors 2025 and 2030
  • 7.3 Bargaining power of suppliers
    • Bargaining power of suppliers - Impact of key factors in 2025 and 2030
  • 7.4 Threat of new entrants
    • Threat of new entrants - Impact of key factors in 2025 and 2030
  • 7.5 Threat of substitutes
    • Threat of substitutes - Impact of key factors in 2025 and 2030
  • 7.6 Threat of rivalry
    • Threat of rivalry - Impact of key factors in 2025 and 2030
  • 7.7 Market condition

8 Market Segmentation by End-user

  • 8.1 Market segments
  • 8.2 Comparison by End-user
  • 8.3 Hospitals and clinics - Market size and forecast 2025-2030
  • 8.4 Research institutes - Market size and forecast 2025-2030
  • 8.5 Pharmaceutical companies - Market size and forecast 2025-2030
  • 8.6 Contract research organizations - Market size and forecast 2025-2030
  • 8.7 Others - Market size and forecast 2025-2030
  • 8.8 Market opportunity by End-user
    • Market opportunity by End-user ($ million)

9 Market Segmentation by Application

  • 9.1 Market segments
  • 9.2 Comparison by Application
  • 9.3 Oncology - Market size and forecast 2025-2030
  • 9.4 Cardiology - Market size and forecast 2025-2030
  • 9.5 Neurology - Market size and forecast 2025-2030
  • 9.6 Infectious diseases - Market size and forecast 2025-2030
  • 9.7 Others - Market size and forecast 2025-2030
  • 9.8 Market opportunity by Application
    • Market opportunity by Application ($ million)

10 Market Segmentation by Modality

  • 10.1 Market segments
  • 10.2 Comparison by Modality
  • 10.3 PET - Market size and forecast 2025-2030
  • 10.4 SPECT - Market size and forecast 2025-2030
  • 10.5 Hybrid imaging systems - Market size and forecast 2025-2030
  • 10.6 Others - Market size and forecast 2025-2030
  • 10.7 Market opportunity by Modality
    • Market opportunity by Modality ($ million)

11 Customer Landscape

  • 11.1 Customer landscape overview
    • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

12 Geographic Landscape

  • 12.1 Geographic segmentation
  • 12.2 Geographic comparison
  • 12.3 North America - Market size and forecast 2025-2030
    • 12.3.1 US - Market size and forecast 2025-2030
    • 12.3.2 Canada - Market size and forecast 2025-2030
    • 12.3.3 Mexico - Market size and forecast 2025-2030
  • 12.4 Europe - Market size and forecast 2025-2030
    • 12.4.1 Germany - Market size and forecast 2025-2030
    • 12.4.2 UK - Market size and forecast 2025-2030
    • 12.4.3 France - Market size and forecast 2025-2030
    • 12.4.4 Italy - Market size and forecast 2025-2030
    • 12.4.5 Spain - Market size and forecast 2025-2030
    • 12.4.6 The Netherlands - Market size and forecast 2025-2030
  • 12.5 Asia - Market size and forecast 2025-2030
    • 12.5.1 China - Market size and forecast 2025-2030
    • 12.5.2 India - Market size and forecast 2025-2030
    • 12.5.3 Japan - Market size and forecast 2025-2030
    • 12.5.4 South Korea - Market size and forecast 2025-2030
    • 12.5.5 Indonesia - Market size and forecast 2025-2030
    • 12.5.6 Thailand - Market size and forecast 2025-2030
  • 12.6 Rest of World (ROW) - Market size and forecast 2025-2030
    • 12.6.1 Brazil - Market size and forecast 2025-2030
    • 12.6.2 Saudi Arabia - Market size and forecast 2025-2030
    • 12.6.3 UAE - Market size and forecast 2025-2030
    • 12.6.4 Turkey - Market size and forecast 2025-2030
    • 12.6.5 Argentina - Market size and forecast 2025-2030
    • 12.6.6 Colombia - Market size and forecast 2025-2030
    • 12.6.7 South Africa - Market size and forecast 2025-2030
    • 12.6.8 Israel - Market size and forecast 2025-2030
  • 12.7 Market opportunity by geography
    • Market opportunity by geography ($ million)
    • Data Tables on Market opportunity by geography ($ million)

13 Drivers, Challenges, and Opportunity

  • 13.1 Market drivers
    • Rising prevalence of chronic disease
    • Technological advancements in hybrid equipment
    • Expansion of precision medicine initiatives
  • 13.2 Market challenges
    • Prohibitive capital investment and maintenance costs
    • Complex regulatory approvals and compliance
    • Short half-life and supply logistical bottlenecks
  • 13.3 Impact of drivers and challenges
    • Impact of drivers and challenges in 2025 and 2030
  • 13.4 Market opportunities
    • Expansion of theranostic agent applications
    • Growth of digital cyclotron infrastructure
    • Rise of quantitative imaging biomarkers

14 Competitive Landscape

  • 14.1 Overview
  • 14.2 Competitive Landscape
    • Overview on criticality of inputs and factors of differentiation
  • 14.3 Landscape disruption
    • Overview on factors of disruption
  • 14.4 Industry risks
    • Impact of key risks on business

15 Competitive Analysis

  • 15.1 Companies profiled
    • Companies covered
  • 15.2 Company ranking index
    • Company ranking index
  • 15.3 Market positioning of companies
    • Matrix on companies position and classification
  • 15.4 Aspect Imaging Ltd.
    • Aspect Imaging Ltd. - Overview
    • Aspect Imaging Ltd. - Product / Service
    • Aspect Imaging Ltd. - Key offerings
    • SWOT
  • 15.5 Bruker Corp.
    • Bruker Corp. - Overview
    • Bruker Corp. - Business segments
    • Bruker Corp. - Key offerings
    • Bruker Corp. - Segment focus
    • SWOT
  • 15.6 Canon Medical Systems Corp.
    • Canon Medical Systems Corp. - Overview
    • Canon Medical Systems Corp. - Product / Service
    • Canon Medical Systems Corp. - Key offerings
    • SWOT
  • 15.7 FUJIFILM Holdings Corp.
    • FUJIFILM Holdings Corp. - Overview
    • FUJIFILM Holdings Corp. - Business segments
    • FUJIFILM Holdings Corp. - Key news
    • FUJIFILM Holdings Corp. - Key offerings
    • FUJIFILM Holdings Corp. - Segment focus
    • SWOT
  • 15.8 GE HealthCare Technologies
    • GE HealthCare Technologies - Overview
    • GE HealthCare Technologies - Business segments
    • GE HealthCare Technologies - Key news
    • GE HealthCare Technologies - Key offerings
    • GE HealthCare Technologies - Segment focus
    • SWOT
  • 15.9 Koninklijke Philips NV
    • Koninklijke Philips NV - Overview
    • Koninklijke Philips NV - Business segments
    • Koninklijke Philips NV - Key news
    • Koninklijke Philips NV - Key offerings
    • Koninklijke Philips NV - Segment focus
    • SWOT
  • 15.10 Lantheus
    • Lantheus - Overview
    • Lantheus - Business segments
    • Lantheus - Key offerings
    • Lantheus - Segment focus
    • SWOT
  • 15.11 LI COR Inc.
    • LI COR Inc. - Overview
    • LI COR Inc. - Product / Service
    • LI COR Inc. - Key offerings
    • SWOT
  • 15.12 MR Solutions Ltd.
    • MR Solutions Ltd. - Overview
    • MR Solutions Ltd. - Product / Service
    • MR Solutions Ltd. - Key offerings
    • SWOT
  • 15.13 Revvity Inc.
    • Revvity Inc. - Overview
    • Revvity Inc. - Business segments
    • Revvity Inc. - Key offerings
    • Revvity Inc. - Segment focus
    • SWOT
  • 15.14 Rigaku Corp.
    • Rigaku Corp. - Overview
    • Rigaku Corp. - Product / Service
    • Rigaku Corp. - Key offerings
    • SWOT
  • 15.15 Shanghai United Imaging
    • Shanghai United Imaging - Overview
    • Shanghai United Imaging - Product / Service
    • Shanghai United Imaging - Key offerings
    • SWOT
  • 15.16 Shimadzu Corp.
    • Shimadzu Corp. - Overview
    • Shimadzu Corp. - Business segments
    • Shimadzu Corp. - Key offerings
    • Shimadzu Corp. - Segment focus
    • SWOT
  • 15.17 Siemens Healthineers AG
    • Siemens Healthineers AG - Overview
    • Siemens Healthineers AG - Business segments
    • Siemens Healthineers AG - Key offerings
    • Siemens Healthineers AG - Segment focus
    • SWOT
  • 15.18 Spectrum Dynamics Medical Inc.
    • Spectrum Dynamics Medical Inc. - Overview
    • Spectrum Dynamics Medical Inc. - Product / Service
    • Spectrum Dynamics Medical Inc. - Key offerings
    • SWOT

16 Appendix

  • 16.1 Scope of the report
    • Market definition
    • Objectives
    • Notes and caveats
  • 16.2 Inclusions and exclusions checklist
    • Inclusions checklist
    • Exclusions checklist
  • 16.3 Currency conversion rates for US$
    • Currency conversion rates for US$
  • 16.4 Research methodology
    • Research methodology
  • 16.5 Data procurement
    • Information sources
  • 16.6 Data validation
    • Data validation
  • 16.7 Validation techniques employed for market sizing
    • Validation techniques employed for market sizing
  • 16.8 Data synthesis
    • Data synthesis
  • 16.9 360 degree market analysis
    • 360 degree market analysis
  • 16.10 List of abbreviations
    • List of abbreviations